Agrin and Perlecan Mediate Tumorigenic Processes in Oral Squamous Cell Carcinoma
Figure 6
Viability of SCC-9 LN-1 and A431 cell lines in 10 µM of cisplatin treatment.
At 10 µM of cisplatin, the viability of SCC-9 (n = 3, A), SCC-9 LN-1 (n = 3, B) and A431 (n = 3C) was significantly reduced when agrin was silenced. Only in A431 cell line the same result of decreasing in viability was observed for perlecan siRNA-knockdown (C) (One-way ANOVA followed by Tukey’s test, different letters indicate statistically difference at p<0.05).